Daily Signal Archive
The Value Signal — daily healthcare value intelligence briefings
The Value Signal — September 08, 2026
202 articles scanned · 5 high-signal
Signal Map
Executive Summary
Medicare Advantage accountability, AI-enabled utilization management, and specialty VBC capital are converging on one question: who captures value when “paying correctly” can mean denying care.
Medicare and Prior Authorization. Medicare Advantage scrutiny is intensifying as The Healthcare Blog argues that “paying correctly” can become a mechanism for paying nothing when beneficiaries face prolonged administrative obstruction. ACP urges Congress to pause the use of AI in prior authorization, positioning algorithmic review as a policy risk before it becomes embedded at scale.
VBC Market and Model Performance. Hcinnovationgroup reports that Thyme is using new funding to build a portfolio of independent oncology businesses, underscoring investor conviction that specialty care remains one of the sharper frontiers for value-based redesign. Amga flags the unrealized promises of value-based care, a reminder that market activity is outpacing proof that VBC consistently delivers better economics and outcomes across provider organizations.
In this edition
- MIPSMACRA at Ten: What a Decade of MIPS Performance Data Says About Physician Payment Adjustments — Medicalresearch
- MedicareWhen “Paying Correctly” Means Paying Nothing: How to Make Medicare Advantage Accountable — The Healthcare Blog
- VBC Market / CompaniesWith New Funding, Thyme to Build Portfolio of Independent Oncology Businesses — Hcinnovationgroup
- Prior AuthorizationACP Urges Congress to Hit Pause on Use of AI in Prior Authorization - American College of Physicians - American College of Physicians | Internal Medicine — ACP
- Value-based CareUnrealized Promises of Value-Based Care - amga.org — Amga